Financial Synergies Wealth Advisors, Inc. Arbutus Biopharma Corp Transaction History

Financial Synergies Wealth Advisors, Inc.

  • $742 Billion
  • Q2 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 12, 2024
SELL
$2.26 - $2.92 $8,475 - $10,950
-3,750 Reduced 51.02%
3,600 $9.29 Million
Q3 2022

Apr 04, 2024
SELL
$1.88 - $2.88 $4,700 - $7,200
-2,500 Reduced 25.38%
7,350 $14 Million
Q2 2022

Apr 04, 2024
BUY
$1.98 - $3.17 $19,503 - $31,224
9,850 New
9,850 $26.7 Million

Others Institutions Holding ABUS

# of Institutions
137
Shares Held
95.4M
Call Options Held
3.44M
Put Options Held
377K
View Full List

About Arbutus Biopharma Corp

ABUS Quotes by TradingView
  • Ticker ABUS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 149,951,008
  • Market Cap $574M
  • Description
  • Arbutus Biopharma Corporation, a biopharmaceutical company, develops novel therapeutics for chronic Hepatitis B virus (HBV) infection, SARS-CoV-2, and other coronaviruses in the United States. Its HBV product pipeline consists of AB-729, a proprietary subcutaneously delivered RNA interference product candidate, which in Phase Ia/Ib clinical tria...
More about ABUS
Track This Portfolio

Track Financial Synergies Wealth Advisors, Inc. Portfolio

Follow Financial Synergies Wealth Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Financial Synergies Wealth Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Financial Synergies Wealth Advisors, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email